Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147

Irish Veterinary Journal

Volumn 57, Issue 11, 2004, Pages 652-656

  Crispie, Fiona ^a   Flynn, James ^a   Ross, R Paul ^a,b   Hill, Colin ^b,c   Meaney, William J ^a  

^a ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Cow; Dry cow therapy; Lacticin; Mastitis; Teat seal; Udder

Indexed keywords

BACTERIOCIN;

CLINICAL RESEARCH; COW; DRUG EFFICACY; MASTITIS; NIPPLE; NONHUMAN; REVIEW; SEAL;

LACTOCOCCUS; LACTOCOCCUS LACTIS; PHOCIDAE;

EID: 8744305814     PISSN: 03680762     EISSN: None     Source Type: Journal    
DOI: 10.1186/2046-0481-57-11-652     Document Type: Review

References (22)

1. Berry, E.A. and Hillerton, J.E. (2002). The effect of selective dry cow treatment on new intramammary infections. Journal of Dairy Science 85: 112-121.
2. Broadbent, J.R., Chou, Y.C., Gillies, K. and Kondo, J.K. (1989). Nisin inhibits several Gram-positive mastitis-causing pathogens. Journal of Dairy Science 72: 3342-3345.
3. Crispie, F., Flynn, J., Ross, R.P., Hill, C. and Meaney, W.J. (2004a). Dry cow therapy with a non-antibiotic intramammary teat seal - a review. Irish Veterinary Journal 57: 412-418.
4. Crispie, F., Twomey, D., Flynn, J., Ross, R. P., Hill, C. and Meaney, W.J. (2004b). The lantibiotic lacticin 3147 produced in a milk-based medium improved the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus. Journal of Dairy Research (in press).
5. Fitzgerald, J.R., Meaney, W.J., Hartigan, P.J., Smyth, C.J. and Kapur, V. (1997). Fine-structure molecular epidemiological analysis of Staphylococcus aureus recovered from cows. Epidemiology and Infection 119: 261-269.
6. Huxley, J.N., Green, M.J., Green, L.E. and Bradley, A.J. (2002). Evaluation of the efficacy of an internal teat sealer during the dry period. Journal of Dairy Science 85: 551-561.
7. Martin, N.L., Sprules, T., Carpenter, M.R., Cotter, P.D., Hill, C., Ross, R.P. and Vederas, J.C. (2004). Structural characterisation of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry 43: 3049-3056.
8. McAuliffe, O., Ryan, M., Ross, R.P., Hill, C., Breeuwer, P. and Abee, T. (1998). Lacticin 3147, a broad-spectrum bactcriocin which selectively dissipates the membrane potential. Applied and Environmental Microbiology 64: 439-445.
9. McAuliffe, O., Hill, C. and Ross, R.P. (2000). Identification and overexpression of LtnI, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147. Microbiology 146: 129-138.
10. Morgan, S.M., Galvin, M., Kelly, J., Ross, R.P. and Hill, C. (1999). Development of a lacticin 3147-enriched whey powder with inhibitory activity against foodborne pathogens. Journal of Food Protection 62: 1011-1016.
11. Pyörälä, S. (2002). New strategies to prevent mastitis. Reproduction in Domestic Animals 37: 211-216.
12. Rea, M.C. and Cogan, T.M. (1994). Buttermilk plants: the Irish version of kefir. The Irish Scientist 2: 7.
13. Rogers, L.A. and Whittier, E.O. (1928). Limiting factors in lactic fermentation. Journal of Bacteriology 16: 211-214.
14. Ryan, M., Meaney, W.J., Ross, R.P. and Hill, C. (1998). Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens. Applied and Environmental Microbiology 64: 2287-2290.
15. Ryan, M.P., Flynn, J., Hill, C., Ross, R.P. and Meaney, W. J. (1999). The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in nonlactating dairy cows. Journal of Dairy Science 82: 2625-2631.
16. Sears, P.M., Smith, B.S., Stewart, W.K., Gonzalez, R.N., Rubino, S.D., Gusik, S.A., Kulisek, E.S., Projan, S.J. and Blackburn, P. (1992a). Evaluation of a nisin-based germicidal formulation on teat skin of live cows. Journal of Dairy Science 75: 3185-3190.
17. Sears, P.M., Wilson, D.J. and Gonzalez, R.N. (1992b). The potential role of antimicrobial proteins in the treatment of bovine mastitis. In: Proceedings of the XVII World Buiatrics Congress, St. Paul, Minnesota, pp 138-142. Edited by E.I. Williams. Stillwater: American Association of Bovine Practitioners.
18. Taylor, J.I., Hirsch, A. and Mattick, A.T.R, (1949). The treatment of bovine streptococcal and staphylococcal mastitis with nisin. Veterinary Record 61: 197-198.
19. Twomey, D.P., Wheelock, A.I., Flynn, J., Meaney, W.J., Hill, C. and Ross, R.P. (2000). Protection against Staphylococcus aureus mastitis in daily cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147. Journal of Dairy Science 83: 1981-1988.
20. Wellenberg, G.J., van der Poel, W.H.M. and Van Oirschot, J.T. (2002). Viral infections and bovine mastitis: a review. Veterinary Microbiology 88: 27-45.
21. Williamson, J.H., Woolford, M.W. and Day, A.M. (1995). The prophylactic effect: of a dry cow antibiotic against Streptococcus uberis. New Zealand Veterinary Journal 43: 228-234.
22. Woolford, M.W., Williamson, A.M. and Copeman, P.A.J. (1998) The prophylactic effect of a teat sealer on mastitis during the dry period and the following lactation. New Zealand Veterinary Journal 46: 12-19.